Routeburn Capital

Routeburn Capital LP is an SEC-registered investment adviser that provides discretionary portfolio management to sleeves of privately pooled investment vehicles (SPPIVs) and other pooled funds rather than to retail individual clients. The firm manages its strategies on behalf of separate pooled vehicles and does not tailor services to individual investors, with regulatory assets under management in the low hundreds of millions.

The firm’s investment work concentrates on biotechnology and pharmaceutical equity securities and may include U.S. and non‑U.S. listed equities, equity‑linked swaps, equity options, listed index options and unlevered exchange‑traded funds. Routeburn describes its strategies as speculative and may employ derivatives, hedging and short‑selling and can maintain concentrated positions and leveraged exposure via swaps, which increases volatility and counterparty risk.

Noteworthy operational features include a small investment team and a recently completed SEC registration, factors the firm identifies as contributing to a limited operating history and key‑person concentration. Routeburn combines a fixed management fee with performance‑based compensation, may use soft‑dollar research arrangements and accesses non‑U.S. equity exposure through swap contracts; it also has a general policy of not voting proxies on behalf of its clients.